Stay updated with breaking news from Biodefense Research Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nancy J. Sullivan of the National Institute of Allergy and Infectious Diseases is the new director of BU’s National Emerging Infectious Diseases Laboratories.
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
MIAMI--(BUSINESS WIRE)--Ridgeback Biotherapeutics (“Ridgeback Bio”), a biotechnology company experienced in antiviral drug development including medicines to treat SARS-Cov-2 and Ebola, announces deployment of the Ridgeback Ebola Rapid Response team to the Democratic Republic of the Congo (DRC). This deployment is an immediate response to the 13th outbreak of Ebola Virus…